Common Contracts

EX-10 10 filename10.htm Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. DATED the 27th day of April, 2015 BETWEEN D3 (Drug Discovery & Development) AND Visterra Inc....

Research Collaboration Agreement • May 5th, 2020

• Contract Type
  Research Collaboration Agreement
• Filed
  May 5th, 2020

D3 (Drug Discovery & Development), Biomedical Sciences Institutes (Co. Registration No. 53239949L), a company incorporated in Singapore and having its principal office at 31 Biopolis Way, 01-02A Nanos, Singapore, 138669 (hereinafter referred to as “D3”) of the first part;

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. DATED the 27th day of April, 2015 BETWEEN D3 (Drug Discovery & Development) AND Visterra Inc. AGREEMENT FOR RESEARCH...

Research Collaboration Agreement • November 4th, 2015 • Visterra, Inc. • Pharmaceutical preparations

• Contract Type
  Research Collaboration Agreement
• Filed
  November 4th, 2015
• Company
  Visterra, Inc.
• Industry
  Pharmaceutical preparations

D3 (Drug Discovery & Development), Biomedical Sciences Institutes (Co. Registration No. 53239949L), a company incorporated in Singapore and having its principal office at 31 Biopolis Way, 01-02A Nanos, Singapore, 138669 (hereinafter referred to as “D3”) of the first part;